health

Experimental Drug Effectively Treats Alzheimer’s in Preclinical Study - SciTechDaily

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern University reports that NU-9, an experimental small-molecule drug currently approved by the U.S. Food and Drug Administration (FDA) for clini…

Source:SciTechDaily
Published:
Experimental Drug Effectively Treats Alzheimer’s in Preclinical Study - SciTechDaily
NU-9, a drug in ALS trials, shows promise in treating Alzheimer’s by preventing toxic protein buildup in brain cells, reducing inflammation, and improving memory in animal models—potentially paving t… [+7621 chars]

Related News